Literature DB >> 24352722

What's in a name?: Goeckerman therapy.

Meredith L Orseth1, Thomas G Cropley2.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24352722     DOI: 10.1001/jamadermatol.2013.7477

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  3 in total

1.  Selected Inflammatory and Metabolic Markers in Psoriatic Patients Treated with Goeckerman Therapy.

Authors:  Katerina Kondelkova; Lenka Borska; Ctirad Andrys; Jan Krejsek; Kvetoslava Hamakova; Simona Rendarova; Vit Rehacek; Jan Kremlacek; Zdenek Fiala
Journal:  Mediators Inflamm       Date:  2015-06-08       Impact factor: 4.711

2.  Serum level of antibody against benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts in people dermally exposed to PAHs.

Authors:  Lenka Borska; Ctirad Andrys; Jan Krejsek; Vladimir Palicka; Marcela Chmelarova; Kvetoslava Hamakova; Jan Kremlacek; Pavel Borsky; Zdenek Fiala
Journal:  J Immunol Res       Date:  2014-04-13       Impact factor: 4.818

3.  Oxidative damage to nucleic acids and benzo(a)pyrene-7,8-diol-9,10-epoxide-DNA adducts and chromosomal aberration in children with psoriasis repeatedly exposed to crude coal tar ointment and UV radiation.

Authors:  Lenka Borska; Ctirad Andrys; Jan Krejsek; Vladimir Palicka; Marcela Chmelarova; Kvetoslava Hamakova; Jan Kremlacek; Zdenek Fiala
Journal:  Oxid Med Cell Longev       Date:  2014-08-12       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.